News from REMEDY

In 2024, Diakonhjemmet hospital has set a new record with 14 doctoral degrees in one year. This marks an important milestone in the work for better treatment and health services. It is the result of a long-term commitment to research and innovation for the benefit of patients. Seven of the doctorates come from the REMEDY centre. 

More than 50,000 Norwegians use a common type of medicine to suppress the immune system. A new study shows that these patients no longer have a high risk of severe covid-19.

Conducting clinical trials requires more than just researchers. Support personnel handle rules, applications and documents. They also contribute to good communication in the studies.

The board of Helse Sør-Est RHF has approved the allocation of regional research funds for 2025. The sum is NOK 149 million for a total of 86 research projects. A significant part of this goes to Diakonhjemmet hospital and projects in the REMEDY portfolio. In the picture, you see three of them who are happy to receive funding for research, PhD scholarship holder Camilla Fongen, senior physician Birgitte Nellemann and professor Sella Provan.

Research shows that patients who participate in their own treatment often get better results. In his PhD project, Joachim Sagen has investigated why user participation is important in the health service. The study looks at how patients' participation can make treatment and rehabilitation more successful. 

We will develop a coordination practice that is simpler and more transparent for everyone involved in the rehabilitation process, says project manager Anne-Lene Sand-Svartrud, Diakonhjemmet hospital. Here together with Anders Bjørneby, Flow Technologies, from the DRIV project group.

The DRIV project receives NOK 400,000 from the Dam Health program and can thus start as planned in April 2025. The aim is to make it easier to coordinate the measures when a patient needs services from several specialist groups, sectors or service levels at the same time.

Physiotherapist Elisabeth Mulrooney (PhD) at Diakonhjemmet hospital has researched the connection between pain and biological, psychological and social factors in patients with hand osteoarthritis.

Sigrid Ødegård, one of Norway's foremost zealots in rheumatology, has been awarded this year's clinician prize by the Norwegian Rheumatology Association (NRF). The award was presented during the NRF's Christmas meeting in 2024, in recognition of her extraordinary efforts.

The organizers were satisfied that the hall was full when the seminar started on 25 November.